Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 2
2012 8
2013 3
2014 15
2015 15
2016 28
2017 33
2018 35
2019 50
2020 39
2021 41
2022 30
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29976287

277 results

Results by year

Filters applied: . Clear all
Page 1
Global Prospective Safety Analysis of Rivaroxaban.
Kirchhof P, Radaideh G, Kim YH, Lanas F, Haas S, Amarenco P, Turpie AGG, Bach M, Lambelet M, Hess S, Camm AJ; Global XANTUS program Investigators. Kirchhof P, et al. J Am Coll Cardiol. 2018 Jul 10;72(2):141-153. doi: 10.1016/j.jacc.2018.04.058. J Am Coll Cardiol. 2018. PMID: 29976287 Free article.
XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America.
Martínez CAA, Lanas F, Radaideh G, Kharabsheh SM, Lambelet M, Viaud MAL, Ziadeh NS, Turpie AGG; XANTUS Investigators. Martínez CAA, et al. Egypt Heart J. 2018 Dec;70(4):307-313. doi: 10.1016/j.ehj.2018.09.002. Epub 2018 Sep 24. Egypt Heart J. 2018. PMID: 30591748 Free PMC article.
Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan.
Miyamoto S, Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Murakawa Y, Iwashiro S, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S. Miyamoto S, et al. J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104584. doi: 10.1016/j.jstrokecerebrovasdis.2019.104584. Epub 2020 Jan 23. J Stroke Cerebrovasc Dis. 2020. PMID: 31983518 Free article.
XANAP: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Asia.
Kim YH, Shim J, Tsai CT, Wang CC, Vilela G, Muengtaweepongsa S, Kurniawan M, Maskon O, Li Fern H, Nguyen TH, Thanachartwet T, Sim K, Camm AJ; XANAP investigators. Kim YH, et al. J Arrhythm. 2018 Jul 6;34(4):418-427. doi: 10.1002/joa3.12073. eCollection 2018 Aug. J Arrhythm. 2018. PMID: 30167013 Free PMC article.
277 results